Apyx Medical Corporation Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
CLEARWATER, Fla., Aug. 07, 2025 (GLOBE NEWSWIRE) -- Apyx Medical Corporation (NASDAQ:APYX) (“Apyx Medical”; the “Company”) today announced that on August 4, 2025, Apyx granted a nonstatuatory sto...
How does this Nasdaq Listing Rule 5635(c)(4) compliance affect the company’s regulatory standing and investor perception?
Will the grant increase the company’s outstanding share count and affect the float or liquidity of the stock?
What are the tax implications for John Featherstone and for Apyx Medical regarding this stock option grant?
19 days ago